Although this study was similar in size to the research you are asking about, it was twice the length
It works similarly and contains the same active ingredient that reduces blood sugar levels and helps people lose weight
It is protective for cartilage cells, and is associated with activation of osteocytes, and thus may be an anabolic factor for bone
Regardless, more convenient needle-free options are on the horizon: Intarcia is developing an implantable GLP-1 agonist therapy called ITCA 650, which aims to remove the hassle of dosing completely
No comparable research exists yet for the injection method, meaning, direct comparison isnt possible at this stage
Excess weight is associated with venous stasis, particularly in the lower limbs, and obesity is a well-established risk factor for venous thromboembolism